Physician profile
Christopher Michael Kapp
NPI 1790027902
$40,094.06
in general payments reported to CMS, 2019-2025
15 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2021: $385 · 2022: $1,586 · 2023: $867 · 2024: $22K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,868 · Food and Beverage: $4,688 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,867.50 |
| Food and Beverage | $4,687.86 |
| Travel and Lodging | $1,111.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $32,409.56 | 2022-2025 | Da Vinci Surgical System |
| Cook Incorporated | $3,867.50 | 2024 | Melker |
| Ethicon INC. | $1,069.28 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $731.91 | 2022-2025 | Imfinzi |
| Erbe USA INC | $650.61 | 2021-2025 | Vio/Cryo/Apc, Vio3 Cryo Apc |
| Boston Scientific Corporation | $456.01 | 2019 | |
| Bard Peripheral Vascular, INC. | $241.77 | 2025 | Pleurx |
| Pinnacle Biologics, INC | $136.86 | 2023 | Photofrin |
| Siemens Medical Solutions USA, INC. | $124.91 | 2025 | |
| Pulmonx Corporation | $105.84 | 2023-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Medtronic, INC. | $100.29 | 2024 | Illumisite |
| Steris Corporation | $89.02 | 2025 | |
| Olympus America INC. | $59.05 | 2024 | Single-Use Flexible Video Bronchoscope |
| Becton, Dickinson and Company | $51.45 | 2024 | Lutonix Drug Coated Balloon |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.